Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

134 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.
Parker LM, Griffiths CT, Yankee RA, Knapp RC, Canellos GP. Parker LM, et al. Among authors: knapp rc. Cancer Treat Rep. 1979 Feb;63(2):275-9. Cancer Treat Rep. 1979. PMID: 312692
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma.
Parker LM, Griffiths CT, Yankee RA, Canellos GP, Gelman R, Knapp RC, Richman CM, Tobias JS, Weiner RS, Frei E 3rd. Parker LM, et al. Among authors: knapp rc. Cancer. 1980 Aug 15;46(4):669-74. doi: 10.1002/1097-0142(19800815)46:4<669::aid-cncr2820460407>3.0.co;2-p. Cancer. 1980. PMID: 7397632
Recombinant leukocyte alpha interferon in advanced ovarian carcinoma.
Niloff JM, Knapp RC, Jones G, Schaetzl EM, Bast RC Jr. Niloff JM, et al. Among authors: knapp rc. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):895-6. Cancer Treat Rep. 1985. PMID: 4016797
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.
Bast RC Jr, Berek JS, Obrist R, Griffiths CT, Berkowitz RS, Hacker NF, Parker L, Lagasse LD, Knapp RC. Bast RC Jr, et al. Among authors: knapp rc. Cancer Res. 1983 Mar;43(3):1395-401. Cancer Res. 1983. PMID: 6825108
Chemotherapy of murine ovarian carcinoma by methotrexate-antibody conjugates.
Burstein S, Knapp R. Burstein S, et al. J Med Chem. 1977 Jul;20(7):950-2. doi: 10.1021/jm00217a018. J Med Chem. 1977. PMID: 69028
Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
Bast RC Jr, Knauf S, Epenetos A, Dhokia B, Daly L, Tanner M, Soper J, Creasman W, Gall S, Knapp RC, et al. Bast RC Jr, et al. Among authors: knapp rc. Cancer. 1991 Oct 15;68(8):1758-63. doi: 10.1002/1097-0142(19911015)68:8<1758::aid-cncr2820680819>3.0.co;2-#. Cancer. 1991. PMID: 1913520
Immunotherapy of ovarian carcinoma. An experimental model.
Order SE, Donahue V, Knapp R. Order SE, et al. Cancer. 1973 Sep;32(3):573-9. doi: 10.1002/1097-0142(197309)32:3<573::aid-cncr2820320309>3.0.co;2-4. Cancer. 1973. PMID: 4125460 No abstract available.
Localization of radiolabelled F(ab')2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts.
Moseley KR, Battaile A, Knapp RC, Haisma HJ. Moseley KR, et al. Among authors: knapp rc. Int J Cancer. 1988 Sep 15;42(3):368-72. doi: 10.1002/ijc.2910420311. Int J Cancer. 1988. PMID: 3417365
Radiation therapy in stage II ovarian carcinoma: the influence of histologic grade.
Mauch PM, Ehrmann RL, Griffiths CT, Marck A, Knapp RC, Levene MB. Mauch PM, et al. Among authors: knapp rc. Cancer. 1980 Mar 15;45(6):1344-51. doi: 10.1002/1097-0142(19800315)45:6<1344::aid-cncr2820450613>3.0.co;2-t. Cancer. 1980. PMID: 6766801
Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.
Kabawat SE, Bast RC Jr, Welch WR, Knapp RC, Bhan AK. Kabawat SE, et al. Among authors: knapp rc. Int J Cancer. 1983 Nov 15;32(5):547-54. doi: 10.1002/ijc.2910320505. Int J Cancer. 1983. PMID: 6358053
134 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page